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Conclusion. Sequential measurement of AV access flow isHemodialysis arteriovenous access: Detection of stenosis and
an acceptable means of both monitoring for the developmentresponse to treatment by vascular access blood flow.
of access stenoses and assessing response to therapy. PTAs ofBackground. Hemodialysis access to the circulation is best
AVF are more durable than PTAs of AV grafts.provided by native and synthetic arteriovenous fistulae (AVF
and AVG). Thromboses caused by venous outflow stenoses pre-
vent the long-term use of AV access. This pilot study was per-
formed to evaluate the ability of ultrasound dilution-derived Hemodialysis vascular access requires repetitive reli-access blood flows to detect AV access stenosis and to evaluate
able access to the circulation [1–4]. This access to thethe response to treatment.
circulation should meet three criteria. First, it shouldMethods. This pilot study was a single-center, prospective
observational intervention trial. The monitoring technique used be suitable for repetitive circulatory access. Second, it
was ultrasound dilution access blood flow measurements per- should allow for a blood flow suitable to conduct modern
formed monthly and after any intervention. Screening criteria high-efficiency dialysis. Third, the complication ratefor interventions were decrements in access flow of 20% when
should be minimal.the flow value fell under 1000 mL/min or absolute flow of ,600
Currently there are three types of hemodialysis vascu-mL/min. The primary intervention when flow criteria were met
was biplanar venography of the access with percutaneous trans- lar access: native arteriovenous fistulas (radiocephalic,
luminal angioplasty (PTA) of detected stenoses. Stenoses unre- brachiocephalic, transposed brachiobasilic, brachiobasi-
sponsive to PTA were sent for surgical revision. Access throm- lic fistulae), arteriovenous (AV) grafts, and central ve-bosis was considered a study ending event.
nous catheters [1–4]. Cuffed tunneled hemodialysis cath-Results. Baseline access flow at study entry for AVF was
eters are the most recent addition to the permanent919 and 1237 mL/min for AVG. Sequential measurement of
AV access flow detected AV access stenosis. PTA and surgical vascular access armamentarium [5]. These vascular access
revision significantly restored AV access flow back toward the devices do a creditable job performing the first two func-
baseline flow measurement. Failure to restore access flow by tions but do have a substantial complication rate [1–4].at least 20% following intervention occurred in 14% of AVF
Complications of hemodialysis vascular access haveand 21% of AVG PTA attempts. Transluminal angioplasty,
emerged as a major cause of patient morbidity and aonce successfully performed, was required at a mean of 5.8-
month intervals in order to maintain AVG flow. In contrast, major cost to the end-stage renal disease (ESRD) pro-
AVF flow was restored for a much longer period of time follow- gram. In its latest report, the U.S. Renal Data System
ing angioplasty (11.4 month follow-up at the time of study end). estimated the cost for access morbidity approaches $8000/Compared with historic controls, which used venous dialysis
patient/year at risk. Health care organizations planningpressure as the primary monitoring technique, the overall
for a capitated environment estimate as much as 25%(AVF-AVG) thrombosis rates improved from 25 to 16% per
patient year, and AVF thrombosis rates improved from 16 to of the total cost of the ESRD program may actually be
7% per patient year. When flow was not successfully restored, spent on the maintenance of vascular access [6–8]. Thus,
thrombosis ensued. Eight of 10 thrombosis episodes were pre- maintenance of access to the circulation has emergeddicted based on inability to improve access flow either as a
not only as a major cause of patient morbidity, but isresult of stenosis treatment failure or unsuccessful referral for
one of the single largest expenses in the United Statestreatment.
ESRD system.
Hemodialysis access failure and morbidity have beenKey words: thrombosis, venous outflow, percutaneous transluminal an-
carefully evaluated. The recent publication of the Na-gioplasty, synthetic arteriovenous fistulae, repetitive circulation access,
high efficiency dialysis. tional Kidney Foundation Dialysis Outcome Quality Ini-
tiative represented the single largest compendium of lit-Received for publication January 25, 2000
erature dealing with hemodialysis vascular access [2].and in revised form July 19, 2000
Accepted for publication July 25, 2000 This group of practice guidelines clearly identified that
primary AV fistulae have superior patency comparedÓ 2001 by the International Society of Nephrology
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with AV grafts, and that patency of all AV access was to be considered successful. Data were collected on ac-
cess flow and all access interventions during the study.significantly improved by prospective monitoring and
therapeutic intervention to resolve venous outflow ste- Retrospective thrombosis data were compiled from this
same dialysis center in the two years before the studynoses. The repetitive measure of hemodialysis access
flow, using various technologies, was identified as a sensi- for comparison. Comparison was performed using paired
t-tests for paired data, unpaired t-test for unpaired data,tive and specific indicator of outflow venous stenosis.
Despite these significant new observations, our under- and rate comparison analysis for historic and study rates.
standing of access flow criteria for intervention and the
Patientsresponse to intervention have not been well delineated.
The purposes of this pilot study, therefore, were (1) to Forty-two patients in a university-based hemodialysis
unit with arteriovenous access were included in the study.evaluate an access flow threshold for access flow moni-
toring in regard to detection of venous outflow stenosis, The mean age of the patients was 61 6 9 years (race,
29 black/13 white; gender, 26 female/16 male). Twenty-(2) to confirm the relationship between AV access flow
and the likelihood of AV access thrombosis, and (3) to six of the 42 patients (62%) had diabetes mellitus as the
cause of ESRD. Total follow-up was 64 patient-yearsdefine the impact of intervention with both percutaneous
transluminal angioplasty (PTA) and surgery on access of hemodialysis (range, 0.6 to 2.4 patient-years; median
follow-up, 1.78 years). There were no eligible patientsflow, and ultimately access thrombosis on of AV fistulae
and AV grafts. excluded from the study. Twenty-four patients (33%)
had native AV fistulae (3 lower arm, 11 upper arm),
while 28 patients dialyzed via AV grafts (67%; 6 lower
METHODS
arm, 18 upper arm, 2 axillary jugular, 1 axillary axillary,
This study represents a single-center pilot, prospective 1 thigh). Upper arm fistulae were brachial cephalic in six
observational intervention study. AV access flows and instances and transposed brachial basilic in five instances.
elective AV access interventions were the evaluated Transposed brachial basilic fistulae were created by ele-
events. Access thrombosis was used as the study ending vation and transposition of the basilic vein across the
event. Access flows were measured monthly and within anterior surface of the upper arm. Patients receiving in-
one week of all interventions. Access flows were mea- center hemodialysis who were training for home hemodi-
sured in the first hour of the hemodialysis treatment. alysis or peritoneal dialysis were deemed ineligible be-
Access flows were performed utilizing the ultrasound cause of the short in-center follow-up (,3 months). Dur-
dilution technique [9, 10]. Access flows measured in the ing the course of the study, three patients died and three
first hour of hemodialysis have been found to be repro- underwent transplantation. There were no patients in
ducible and relatively unaffected by the falls in cardiac the facility receiving hemodialysis via an AV access who
output associated with ultrafiltration [11]. Elective access were maintained on Warfarin or other form of systemic
interventions were transluminal angioplasty and surgical anticoagulation. Monthly flow measurements were per-
revision. Prior to elective intervention, all AV accesses formed on all patients in the facility with an AV access
were evaluated by contrast fistulography. Radiocontrast as part of the facility access monitoring program when
fistulography was performed as previously described the facility converted from daily dynamic venous pres-
[12]. Radiocontrast fistulography was performed for any sure monitoring. At the time of study entry, there were
20% decrement in access flow when the access flow was no patients with a detected access flow of less than 750
,1000 mL/min or when absolute access flow decreased mL/min.
to under 600 mL/min. These flow parameters were cho-
sen based on results obtained in our preliminary trial
RESULTSand on previously published findings [10]. Any access
stenosis .50% of the lumen diameter (as determined by Figure 1 depicts the mean access flow at study entry
and end for the study group as a whole. Figure 1 alsobiplanar angiography) when associated with a significant
flow decrement was initially treated with transluminal shows access flow by type of access (AVF-AVG), for
the intervention group pre- and post- all PTA (RX; byangioplasty (using our previously described technique)
[12] performed at the time of fistulogram. Patients were AVF-AVG) and at the study end for the intervention
group alone. Thirty-seven referrals for diagnostic veno-referred for surgical revision following failure of PTA
to restore access flow by .20% of the baseline. Interven- gram of the AV access were done for study indications.
All 37 referrals were performed because a falling accesstion success for the purpose of the study was defined by
an increase in access flow .20% of the baseline mea- flow threshold was met (33 flow decrements, 4 absolute
flow). Thirty-five diagnostic venogram evaluations of thesured within one-week post-procedure. This value of
20% was selected based on the concept that flow should AV access were performed. Two referrals did not keep
evaluation appointments, and both thrombosed. All 35be restored at least to the extent of the screening criteria
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Table 1. Thromboses
Thromboses
per PTA Surgical
Thromboses HD year predicted PTA HD year revision
All 10 0.156 8 35 0.359 4
AVF 2 0.074 2 7 0.26 0
AVG 8 0.216 6 28 0.75 4
Abbreviations are: AVF, native arteriovenous fistulae; AVG, synthetic arte-
riovenous fistulae; HD, hemodialysis; PTA, percutaneous transluminal angi-
oplasty.
for all access that were still patent is also shown (Fig. 1).
Fig. 1. Arteriovenous (AV) access flow measured in mL/min (y axis) These end-study data represent all patients and include
at key study times in the study (x axis). Groups designated “All” repre- those with and without an intervention.sent all AV access active in the study. Groups designated RX represent
Mean time from first to second PTA was 5.8 monthsintervention groups only. Values are reported 6 SEM. P , 0.05 (study
entry vs. pre-first rx); P , 0.05 (pre-first rx vs. post-first rx); P , 0.05 in AV grafts. This could not be calculated for AVFs
(post-first rx vs. pre-2nd rx); P , 0.05 (pre-2nd rx vs. post-2nd rx). because there was only one repeat intervention. MeanSymbols are: ( ) fistula; (j) graft.
follow-up post-PTA for AVF stood at 11.4 months at
study closure. Three patients (3 of 7 PTA failures) de-
ferred surgical revision, as described later in this article.
successful referrals underwent venography of the access. Elective surgical revisions occurred in four patients, all
All 35 were found to have a .50% stenosis in the AV with AV grafts. Mean increase in flow post-surgical revi-
access and underwent PTA. There were no study veno- sion was 655 6 88 to 891 6 136 mL/min (P , 0.05).
grams performed that did not detect a .50% access During the study period that encompassed 64 patient-
stenosis. Stenoses in AV grafts occurred primarily at or years of hemodialysis, there were 10 episodes of throm-
within 6 cm of the vein graft anastomoses (74%). The bosis (Table 1); this calculates to a total thrombosis rate
remainder occurred more proximally in the venous circu- of 0.156 or on average 16% per patient-year. The throm-
lation with one innominant vein stenosis. There were no bosis rate per patient-year of hemodialysis for AVF was
arterial and only one intragraft stenoses detected. In AV considerable less than for AV grafts (0.216, AVG vs.
fistulae, there was one central vein stenosis, with the 0.074, AVF; P , 0.05). Eight of the 10 thromboses were
remainder occurring in the venous outflow tract at sites predicted in that they occurred in patients who had an
of vein bifurcation and venous valves. unsuccessful PTA and who were unwilling to undergo
Two patients were referred for venography by vascular elective surgical revision or in whom a fistulogram was
surgery consultants for various indications independent recommended and who postponed or canceled their fis-
of flow criteria (AV fistula aneurysm evaluation, pseudo tulogram appointment (AV grafts thrombosed within 4
aneurysm evaluation) independent of the study. In addi- months of diminished flow, AV fistulae within 1 year of
tion following completion of the study, seven patients diminished flow). Two thromboses occurred in patients
(3 AVF and 4 AVG) were evaluated with biplanar ven- in whom access flow did not detect a significant drop
ography for nonflow indications (access pain, bleeding in flow. Their previous access history did not appear
post-needle removal, difficult fistula cannulation). There different from the group as a whole.
was one significant (50%) stenosis detected in these nine Percutaneous transluminal angioplasty was a common
patients. PTA of this stenosis had no effect on access event in the study. There were 0.359 PTA per patient-
flow. year of hemodialysis (36% per patient-year; Table 1).
There was a total of 35 PTA (successful and unsuccess- The intervention rate was much higher in AVG than in
ful) during the study. There were 15 primary, 11 second- AVF (0.75 compared with 0.26, P , 0.05; Table 1). The
ary, and 2 tertiary PTAs in patients with AV grafts. mean time between the first and second interventions in
There were six primary and one secondary PTA in the AVG was 5.8 months. There were not enough second
AVF group. Failure to increase flow by 20% post-PTA interventions in AVF to calculate a rate. In all instances
defined failure of PTA. This occurred in 14% of fistula except one, the repeat interventions were performed on
PTA attempts (1 of 7 PTA) and in 21% of AV graft (6 a recurrent and not a new stenosis.
of 28 PTA). Access flow results pre- and post-PTA are When patients rather than episodes of referral were
graphically represented in Figure 1. All PTA attempts examined, PTA was performed in 15 of 28 patients with
are recorded in this figure, including those deemed suc- AV grafts (54%) and in 6 of 14 patients with AVF (43%).
The thrombosis rate for this study overall was 0.156cessful and unsuccessful. Flow at the end of the study
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or 16% per patient-year. Our previous thrombosis rate PTAs are successful despite the impression of physician
performing the procedure. When follow-up flow mea-for this same unit for the two years preceding the study
was 0.251 or 25% per patient-year using dynamic venous sures were performed, 14% of AVF and 21% of AVG
PTA failed to improve flow .20%. The mean period ofpressure as the primary screening technique (P , 0.05).
When compared by access type, the rate of thrombosis time between a successful intervention and the need for
repeat intervention is approximately 5.8 months in AVfor AVF was 7% during the study and 16% during in
the preceding two years (P , 0.05). The thrombosis rate grafts. Thus, intimal and fibromuscular hyperplasia pro-
ceeds regardless of the intervention. Repetitive translu-for grafts was 22% during the study and 30% during the
preceding two years (P 5 NS). minal angioplasty successfully returns lower and lower
fractions of overall access flow as outlined in Figure 1.
Thus, although prospective intervention significantly
DISCUSSION
modifies vascular anatomy to allow continued flow, ideal
The concept of prospective monitoring with elective long-term therapy should be prevention of this underly-
intervention to maintain patency of AV access has been ing biologic event. Nonetheless, as is clear from this
substantiated in multiple clinical trials [1, 2, 13–19]. Our observation, successful angioplasty and surgical revision
prospective, observational pilot study evaluated and ex- continue to return flow back in a positive manner in the
tended the role of access flow monitoring in an overall direction of the previous baseline. The article also shows
hemodialysis access maintenance program, and suggests that surgical revision is capable of salvaging PTA failures
that monitoring with access flow has benefits beyond in AV grafts.
using dynamic venous pressure as a monitoring tool, Interestingly, intervention in AV fistulae appears to
especially in AV fistulae. be more durable than interventions in AV grafts (mean
This study suggests that the trend of access flow is as follow-up .11 months at study end). The reason for this
important as the overall access flow. Decrements in ac- remarkably better durability is unclear (Table 1 and Fig.
cess flow .20%, when the flow was less than 1000 mL/ 1). We speculate that either the PTA allows time for
min, were highly predictive of a significant AV access collaterals to develop in AVFs or intimal and fibromus-
stenosis and when flow was not restored, predictive of cular hyperplasia occurs at a slower rate in AVFs.
access thrombosis. All patients who met these criteria Thrombosis rates overall and most marked thrombosis
and who underwent fistulogram had a significant stenosis rates in AVF were improved in this prospective, access-
either within the AV access or in the venous outflow flow pilot trial compared with retrospective controls
tract. The vast majority of interventions occurred be- screening with dynamic venous dialysis pressure. The
cause of decrements in access flow and not for absolute improvement was most striking in AV fistula, where
flow criteria. The study also confirmed that failure to the thromboses rate improved from 16% percentage per
restore access flow led to a high likelihood of access patient-year to 7%. This is even more important when
thrombosis. There was a total of 10 access thromboses one considers that most thromboses in AV fistulae result
during the study period. Eight of these 10 were predicted in access loss because thrombectomy and thrombolysis
by falling access flow measurements. In these eight in- are difficult to perform in AVF. Recent observations are
stances, the patients failed to keep their appointment changing this trend, but most U.S. centers, including
for prospective fistulogram or for access revision in the ours, still have limited success in salvaging a fistula after
case of PTA failure. Only two episodes of thromboses thrombosis [20]. AVG thrombosis rates were also im-
occurred that were not expected based on access flow proved (30 to 22%) but did not reach statistical signifi-
measurements. Thus, decrements of .20% in AV access cance. Thus, in our pilot study, monitoring for flow had
flow, when the flows are ,1000 mL/min, appear to be advantages over pressure monitoring as a monitoring
predictive of a hemodynamically significant access steno- technique. The significant new message is the value of
sis and an ultimate thrombosis. Patients without a fall flow monitoring and prospective PTA in AV fistulae.
in access flow were unlikely to have a hemodynamically Not only does it appear that thromboses are avoided,
significant stenosis. An alternate screening approach but unlike AV grafts, the correction appears to be more
could have been to attempt to determine an absolute durable.
flow decrement rate as a monitor threshold rather than An appropriate criticism of this concept is that moni-
percentage decrement. We choose the percentage decre- toring especially of AV grafts merely replaces one inter-
ment for this pilot study based on our previous experi- vention with another (Table 1). The number of interven-
ence. tions, both transluminal angioplasty and hemodialysis
This study confirms that successful PTA or surgical vascular access revision, was 0.359 or 36% per patient
access revision can restore flow. It also outlines that year. When AVG grafts alone are examined, the inter-
repetitive interventions become progressively less suc- vention rate to maintain patency was 0.75 interventions
per patient year. Nonetheless, the use of an elective outpa-cessful over time in AV grafts. It confirms that not all
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